SCHEMBL7777237

SCHEMBL7777237

NS(=O)(=O)c1ccc(-c2n[nH]cc2-c2cc(Cl)ccc2Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 11/20 0.48
PTGS1 P23219 7/20 0.48
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
TTK P33981 1/20 0.44
ENPP3 O14638 1/20 0.43
CA1 P00915 3/20 0.42
CA2 P00918 3/20 0.42
CA12 O43570 2/20 0.42
CA9 Q16790 2/20 0.42
CA3 P07451 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42
CA7 P43166 1/20 0.42
CA13 Q8N1Q1 1/20 0.42
CA14 Q9ULX7 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
MAOA P21397 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7777653 0.90 PTGS2 (0.48) PTGS2PTGS1TTKCA1CA2
SCHEMBL7779700 0.87 PTGS2 (0.48) PTGS2PTGS1
SCHEMBL7779438 0.85 CA1 (0.54) PTGS2PTGS1TTKCA1CA2
SCHEMBL7778280 0.85 PTGS2 (0.62) PTGS2PTGS1TTKENPP3CA1
SCHEMBL7780688 0.84 MAOA (0.52) PTGS2PTGS1TTKCA1CA2
SCHEMBL7777335 0.82 CA2 (0.54) PTGS2PTGS1TTKCA1CA2
SCHEMBL8629390 0.81 PTGES2 (0.43) PTGS2CA1CA2CA12CA9
SCHEMBL7779189 0.78 PTGS2 (0.62) PTGS2PTGS1LMNATTKCA1
SCHEMBL7777637 0.77 PTGS2 (0.53) PTGS2PTGS1
SCHEMBL7779777 0.76 PTGS2 (0.49) PTGS2PTGS1TTKCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed